MIR5189: A Drug Target / Disease Biomarker (G100847057)

Target Name: MIR5189

NCBI ID: G100847057

MIR5189

MIR5189: A Drug Target / Disease Biomarker

MIR5189 is a drug target and a biomarker that is being studied for its potential utility in treating various diseases, including cancer. MIR5189 is a small interfering RNA (siRNA) that targets the protein PD-L1, which is a protein that is expressed in many types of cancer cells.

PD-L1 is a protein that is expressed in many different types of cancer cells, including melanoma, lung cancer, and ovarian cancer. It is believed to play a role in the development and progression of these types of cancer by enabling the cancer cells to evade the immune system.

One way to treat cancer is to use antibodies that recognize and target specific proteins that are expressed in the cancer cells. This is known as targeted therapy. By using antibodies that recognize PD-L1, researchers have been able to block its effects and inhibit its ability to suppress the immune system.

MIR5189 is also being studied as a potential biomarker for cancer. By using MIR5189 as a treatment, researchers have been able to track the progress of the cancer and monitor the levels of PD-L1 in the body. This has allowed researchers to see how the treatment is affecting the body and to make adjustments as needed.

In addition to its potential use as a cancer treatment, MIR5189 is also being studied for its potential use as a biomarker. By using MIR5189 as a treatment, researchers have been able to track the levels of PD-L1 in the body and to see how it is affected by the treatment. This has allowed researchers to monitor the effectiveness of the treatment and to make adjustments as needed.

Overall, MIR5189 is a promising drug target and biomarker that is being studied for its potential utility in treating cancer. With further research, it may be able to provide a new treatment option for people with this disease.

Protein Name: MicroRNA 5189

The "MIR5189 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR5189 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets